Skin adnexal neoplasms - Part 2: An approach to tumours of cutaneous sweat glands

Journal of Clinical Pathology

Volumn 60, Issue 2, 2007, Pages 145-159

  Obaidat, Nidal A ^b   Alsaad, Khaled O ^b   Ghazarian, Danny ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADNEXA DISEASE; APOCRINE GLAND; DISEASE CLASSIFICATION; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN ADNEXAL NEOPLASM; SKIN DEFECT; SKIN TUMOR; SWEAT GLAND CARCINOMA; SWEAT GLAND TUMOR; SYRINGOFIBROADENOMA; SYRINGOMA;

ADENOMA, PLEOMORPHIC; ADENOMA, SWEAT GLAND; CARCINOMA, SKIN APPENDAGE; HUMANS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; SWEAT GLAND NEOPLASMS; SYRINGOMA;

EID: 33846977700     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.041608     Document Type: Review

References (110)

1. Klein W, Chan E, Seykora JT. Tumors of the epidermal appendages. In:Elder DE (Editor-in-Chief). Lever's histopathology of the skin.9th edn. Philadelphia, PA: Lippincott Williams & Wilikins, 2005:867-926.
2. Weedon D. Tumors of cutaneous appendages. In:Weedon D.Skin pathology.2nd adn. Edinburgh: Churchill Livingstone, 2002:859-916.
3. Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms - part 1 : an approach to tumours of the pilosebaceous unit. J Clin Pathol 2006;60:129-44.
4. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999;12:786-93.
5. Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med 2002;126:591-4.
6. Wallace MI, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995;8:897-901.
7. Honma N, Takubo K, Akiyama F, et al. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Histopathology 2005;47:195-201.
8. van der Putte SC. Apoeccrine glands in nevus sebaceous. Am J Dermatopathol 1994;16:23-30.
9. Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. J Am Acad Dermatol 2003;48:453-5.
10. Pfeifer JD, Barr RJ, Wick MR. Ectopic breast tissue and breast-like sweat gland metaplasias: an overlapping spectrum of lesions. J Cutan Pathol 1999;26:190-6.
11. van der Putte SC. Mammary-like glands of the vulva and their disorders. Int J Gynecol Pathol 1994;13:150-60.
12. Abbott JJ, Ahmed I. Adenocarcinoma of mammary-like glands of the vulva: report of a case and review of the literature. Am J Dermatopathol 2006;28:127-33.
13. Nishie W, Sawamura D, Mayuzumi M, et al. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands. J Cutan Pathol 2004;31:561-4.
14. Chen YH, Wong TW, Lee JYY. Depigmented genital extramammary Paget's disease: a possible histogenetic link to Toker's clear cells and clear cell papulosis. J Cutan Pathol 2001;28:105-8.
15. Garcia-Rio I, Perez-Gala S, Fraga J, et al. Eccrine squamous syringometaplasia in a patient with systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2006;20:608-10.
16. Kakinuma H, Miyamoto R, Iwasawa U, et al. Three subtypes of poroid neoplasia in a single lesion: eccrine poroma, hidroacanthoma simplex, and dermal duct tumor. Histologic, histochemical, and ultrastructural findings. Am J Dermatopathol 1994;16:66-72.
17. Wick MR, Swanson PE, Barnhill RL. Sweat gland tumors. In: Barnhill RL, eds. Textbook of dermatopathology.2nd edn. New York: McGraw-Hill, 2004:745-84.
18. Yamamoto O, Hisaoka M, Yasuda H, et al. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells. J Cutan Pathol 2000;27:367-73.
19. Kamiya H, Oyama Z, Kitajima Y. "Apocrine" poroma: review of the literature and case report. J Cutan Pathol 2001;28:101-4.
20. Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med 2001;125:498-505.
21. Robson A, Greene J, Ansari N, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001;25:710-20.
22. Maeda T, Mori H, Matsuo T, et al. Malignant eccrine poroma with multiple visceral metastases: report of a case with autopsy findings. J Cutan Pathol 1996;23:566-70.
23. Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol 2006;19(Suppl 2):S93-126.
24. Patterson JW, Wick MR. Neoplasms and pseudoneoplastic proliferations of the sweat glands. In: Silverbeg SG, Sobin LH, eds. AFIP Atlas of tumor pathology. Non-melanocytic tumors of the skin. Washington, DC: Armed Forces Institute of Pathology, 2006:137-99.
25. Herwig EB. Eccrine acrospiroma. J Cutan Pathol 1984;11:415-20.
26. Headington JT, Niederhuber JE, Beals TF. Malignant clear cell acrospiroma. Cancer 1978;41:641-7.
27. Gortler I, Koppl H, Stark GB, et al. Metastatic malignant acrospiroma of the hand. Eur J Surg Oncol 2001;27:431-5.
28. Soler-Carrillo J, Estrach T, Mascaro JM. Eruptive syringoma: 27 new cases and review of the literature. J Eur Acad Dermatol Venereol 2001;15:242-6.
29. Guitart J, Rosenbaum MM, Requena L. "Eruptive syringoma": a misnomer for a reactive eccrine gland ductal proliferation? J Cutan Pathol 2003;30:202-5.
30. Patrizi A, Neri I, Marzaduri S, et al. Syringoma: a review of twenty-nine cases. Acta Dermatol Venereol 1998;78:460-2.
31. Ohnishi T, Watanabe S. Immunohistochemical analysis of keratin expression in clear cell syringoma. A comparative study with conventional syringoma. J Cutan Pathol 1997;24:370-6.
32. Ohnishi T, Kaneko S, Egi M, et al. Syringoid eccrine carcinoma: report of a case with immunohistochemical analysis of cytokeratin expression. Am J Dermatopathol 2002;24:409-13.
33. Storm CA, Seykora JT. Cutaneous adnexal neoplasms. Am J Clin Pathol 2002;118:533-49.
34. Satter EK, Graham BS. Chondroid syringoma. Cutis 2003;71:49-52.
35. Yamamoto O, Yasuda H. An immunohistochemical study of the apocrine type of cutaneous mixed tumors with special reference to their follicular and sebaceous differentiation. J Cutan Pathol 1999;26:232-41.
36. Nather A, Sutherland IH. Malignant transformation of a benign cutaneous mixed tumour. J Hand Surg [Br] 1986;11:139-43.
37. Metzler G, Schaumburg-Lever G, Hornstein O, et al. Malignant chondroid syringoma: immunohistopathology. Am J Dermatopathol 1996;18:83-9.
38. Bates AW, Baithun SI. Atypical mixed tumor of the skin: histologic, immunohistochemical, and ultrastructural features in three cases and a review of the criteria for malignancy. Am J Dermatopathol 1998;20:35-40.
39. Takeda H, Mitsuhasni Y, Hayashi M, et al. Eccrine syringofibroadenoma: case report and review of the literature. J Eur Acad Dermatol Venereol 2000;15:147-9.
40. Fouilloux B, Perrin C, Dutoit M, et al. Clear cell syringofibroadenoma (of Mascaro) of the nail. Br J Dermatol 2001;144:625-7.
41. Uede K, Yamamoto Y, Furukawa F. Brooke-Spiegler syndrome associated with cylindroma, trichoepilhelioma, spiradenoma and syringoma. J Dermatol 2004;31:32-8.
42. Michal M. Spiradenoma associated with apocrine adenoma component. Pathol Res Pract 1996;192:1135-9.
43. Granter SR, Seeger K, Calonje E, et al. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol 2000;22:97-103.
44. Leonard N, Chaggar R, Jones C, et al. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 2001;54:689-92.
45. Penneys NS, Kaiser M. Cylindroma expresses immunohistochemical markers linking to eccrine coil. J Cutan Pathol 1993;20:40-3.
46. Tellechea O, Reis JP, Marques C, et al. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma? Am J Dermatopathol 1995;17:499-505.
47. Michal M, Lamovec J, Mukensnabl P, et al. Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases. Pathol Int 1999;49:419-25.
48. Meybehm M, Fischer HP. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations. Am J Dermatopathol 1998;20:315-17.
49. Gerretsen AL, van der Putte SC, Deenstra W, et al. Cutaneous cylindroma with malignant transformation. Cancer 1993;72:1618-23.
50. Durani BK, Kurzen H, Jaeckel A, et al. Malignant transformation of multiple dermal cylindromas. Br J Dermatol 2001;145:653-6.
51. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceous: a study of 596 cases. J Am Acad Dermatol 2000;42:263-8.
52. Coyne JD, Fitzgibbon JF. Mixed syringocystadenoma papilliferum and papillary eccrine adenoma occurring in a scrotal condyloma. J Cutan Pathol 2000;27:199-201.
53. Ansai S, Watanabe S, Aso K. A case of tubular apocrine adenoma with syringocystadenoma papilliferum. J Cutan Pathol 1989;16:230- 6.
54. Boni R, Xin H, Hohl D, et al. Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol 2001;23:87-9.
55. Vanatta PR, Bangert JL, Freeman RG. Syringocystadenoma papilliferum. A plasmacytoid tumor. Am J Surg Pathol 1985;9:678- 83.
56. Yamamoto O, Doi Y, Hamada T, et al. An immunohistochemical and ultrastructural study of syringocystadenoma papilliferum. Br J Dermatol 2002;147:936-45.
57. Ishida-Yamamoto A, Sato K, Wada T, et al. Syringocystadenocarcinoma papilliferum: case report and immunochemical comparison with its benign counterpart. J Am Acad Dermatol 2001;45:755-9.
58. Loane J, Kealy WF, Mulcahy G. Perianal hidradenoma papilliferum occurring in a male: a case report. Irish J Med Sci 1998;167:26-7.
59. Vang R, Cohen PR. Ectopic hidradenoma papilliferum: a case report and review of the literature. J Am Acad Dermatol 1999;41:115-118.
60. Handa Y, Yamanaka N, Inagaki H, et al. Large ulcerated perianal hidradenoma papilliferum in a young female. Dermatol Surg 2003;29:790-2.
61. Kazakov DV, Mikyskova I, Kutzner H, et al. Hidradenoma papilliferum with oxyphilic metaplasia: a clinicopathological study of 18 cases, including detection of human papillomavirus. Am J Dermatopathol 2005;27:102-10.
62. Pelosi G, Martignoni G, Bonetti F. Intraductal carcinoma of mammary-type apocrine epithelium arising within a papillary hydradenoma of the vulva. Report of a case and review of the literature. Arch Pathol Lab Med 1991;115:1249-54.
63. Tamaki K, Furue M, Matsukawa A, et al. Presence and distribution of carcinoembryonic antigen and lectin-binding sites in benign apocrine sweat gland tumours. Br J Dermatol 1985;113:565-71.
64. Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am J Dermatopathol 1988;10:28-35.
65. Ansai S, Koseki S, Hozumi Y, et al. An immunohistochemical study of lysosome, Cd-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specifity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol 1995;17:249-55.
66. Offidani A, Campanati A. Papillary hidradenoma: immunohistochemical analysis of steroid receptor profile with a focus on apocrine differentiation. J Clin Pathol 1999;52:829-32.
67. Higgins CM, Strutton GM. Papillary apocrine fibroadenoma of the vulva. J Cutan Pathol 1997;24:256-60.
68. Assor D, Davis JB. Multiple apocrine fibroadenomas of the anal skin. Am J Clin Pathol 1977;68:397-9.
69. Donati P, Amantea A. Adenoma of anogenital mammary-like glands. Am J Dermatopathol 1996;18:73-6.
70. Falck VG, Jordaan HF. Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation. Am J Dermatopathol 1986;8:64-72.
71. Fox SB, Cotton DW. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity? Am J Dermatopathol 1992;14:149-54.
72. Megahed M, Holzle E. Papillary eccrine adenoma. A case report with immunohistochemical examination. Am J Dermatopathol 1993;15:150- 5.
73. Ishiko A, Shimizu H, Inamoto N, Nakmura K. Is tubular apocrine adenoma a distinct clinical entity? Am J Dermatopathol 1993;15:482-7.
74. Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol 1997;19:358-62.
75. Lei JY, Wang Y, Jaffe ES, et al. Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. Am J Dermatopathol 2000;22:524-9.
76. Bogner PN, Su LD, Fullen DR. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin. J Cutan Pathol 2005;32:50-4.
77. Ban M, Sugie S, Kamiya H, et al. Microcystic adnexal carcinoma with lymph node metastasis. Dermatology 2003;207:395-7.
78. Fischer S, Breuninger H, Metzler G, et al. Microcystic adnexal carcinoma: an often misdiagnosed, locally aggressive growing skin tumor. J Craniofac Surg 2005;16:53-8.
79. Kazakov DV, Suster S, LeBoit PE, et al. Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol 2005;29:764-82.
80. Breier F, Clabian M, Pokieser W, et al. Primary mucinous carcinoma of the scalp. Dermatology 2000;200:250-3.
81. Hanby AM, McKee P, Jeffery M, et al. Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptors and progesterone receptors. Am J Surg Pathol 1998;22:1125-31.
82. van der Kwast TH, Vuzevski VD, Ramaekers F, et al. Primary cutaneous adenoid cystic carcinoma: case report, immunohistochemistry, and review of the literature. Br J Dermatol 1988;118:567-77.
83. Chu SS, Chang YL, Lou PJ. Primary cutaneous adenoid cystic carcinoma with regional lymph node metastasis. J Laryngol Otol 2001;115:673-5.
84. Bergman R, Lichtig C, Moscona RA, et al. A comparative immunohistochemical stuay of adenoid cystic carcinoma of the skin and salivary glands. Am J Dermatopathol 1991;13:162-8.
85. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 2003;16:1224-31.
86. Kao GF, Melwig EB, Graham JH. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations. J Cutan Pathol 1987;14:129-46.
87. Duke WH, Sherrod TT, Lupton GP. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). Am J Surg Pathol 2000;24:775-84.
88. Jih DM, Elenitsas R, Vittorio CC, et al. Aggressive digital papillary adenocarcinoma: a case report and review of the literature. Am J Dermatopathol 2001;23:154-7.
89. Malafa MP, McKesey P, Stone S, et al. Sentinel node biopsy for staging of aggressive digital papillary adenocarcinoma. Dermatol Surg 2000;26:580-3.
90. Chamberlain RS, Huber K, White JC, et al. Apocrine gland carcinoma of the axilla. Review of the literature and recommendations for treatment. Am J Clin Oncol 1999;22:131-5.
91. Miyamoto T, Hagari Y, lnoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol 2005;58:757-61.
92. Paties C, Taccagni GL, Papotti M, et al. Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer 1993;15, 71:375-81.
93. Dalles S, Skowron F, Balme B, et al. Apocrine carcinoma developed in nevus sebaceus of Jadassohn. Eur J Dermatol 2003;13:487-9.
94. MacNeill KN, Riddell RH, Ghazarian D. Perianal apocrine adenocarcinoma arising in a benign apocrine adenoma; first case report and review of the literature. J Clin Pathol 2005;58:217-9.
95. Obaidat NA, Awamleh AA, Ghazarian DM. Adenocarcinoma in situ arising in a tubulopapillary apocrine hidradenoma of the peri-anal region: a report or the first case. Eur J Dermatol 2006;16:576-8.
96. Willman JH, Golitz LE, Fitzpatrick JE. Vulvar clear cells of Toker: precursors of extramammary Paget's disease. Am J Dermatopathol 2005;27:185-8.
97. Diaz de Leon E, Carcangiu ML, Prieto VG, et al. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol 2000;113:572-5.
98. Liegl B, Horn LC, Moinfar F. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol 2005;18:1283-8.
99. Goldblum JR, Hart WR. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 1997;21:1178-87.
100. McKee PH, Hertogs KT. Endocervical adenocarcinoma and vulval Paget's disease: a significant association. Br J Dermatol 1980;103:443-8.
101. Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 1997;108:6-12.
102. Allan SJ, McLaren K, Aldridge RD. Paget's disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma. Br J Dermatol 1998;138:689-91.
103. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002;33:549-54.
104. Rayne SC, Santa Cruz DJ. Anaplastic Paget's disease. Am J Surg Pathol 1992;16:1085-91.
105. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol 2004;26:447-51.
106. Apisammanarax P, Bovenmyer DA, Mehregan AH. Combined adnexal tumor of the skin. Arch Dermatol 1984;120:231-3.
107. Poomeechaiwong S, Bonelli JE, Golitz LE. Mixed tumor of the pilosebaceous type: mixed tumor of the skin with apocrine, follicular and sebaceous differentiation. J Cutan Pathol 1988;15:33-8.
108. Sanchez Yus E, Requena L, Simon P, et al. Complex adnexal tumor of the primary epithelial germ with distinct patterns of superficial epithelioma with sebaceous differentiation, immature trichoepithelioma, and apocrine adenocarcinoma. Am J Dermatopathol 1992;14:245-52.
109. Wong TY, Suster S, Cheek RF, et al. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation: clinicopathologic and immunohistochemical study of eight cases. Am J Dermatopathol 1996;18:124-36.
110. Obaidat NA, Ghazarian DM. A 'proliferating' composite adnexal tumour of the penis: report of the first case. J Clin Pathol 2006. In press.